Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337198![]() (US9745291, Compound 244) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337210![]() (US9745291, Compound 257) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337213![]() (US9745291, Compound 260) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337215![]() (US9745291, Compound 262) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM336980![]() (US9745291, Compound 26 | US9765068, Compound 26) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM336993![]() (US9745291, Compound 39 | US9765068, Compound 39) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337024![]() (US9745291, Compound 70 | US9765068, Compound 70) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337028![]() (US9745291, Compound 74 | US9765068, Compound 74) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337029![]() (US9745291, Compound 75 | US9765068, Compound 75) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337033![]() (US9745291, Compound 79 | US9765068, Compound 79) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337064![]() (US9745291, Compound 110 | US9765068, Compound 110) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337103![]() (US9745291, Compound 149 | US9765068, Compound 149) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337113![]() (US9745291, Compound 159 | US9765068, Compound 159) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337118![]() (US9745291, Compound 164 | US9765068, Compound 164) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337145![]() (US9745291, Compound 191 | US9765068, Compound 191) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337186![]() (US9745291, Compound 232) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337227![]() (US9745291, Compound 274) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337031![]() (US9745291, Compound 77 | US9765068, Compound 77) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337042![]() (US9745291, Compound 88 | US9765068, Compound 88) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337054![]() (US9745291, Compound 100 | US9765068, Compound 100) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337124![]() (US9745291, Compound 170 | US9765068, Compound 170) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337179![]() (US9745291, Compound 225) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337204![]() (US9745291, Compound 250) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337230![]() (US9745291, Compound 277) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM336981![]() (US9745291, Compound 27 | US9765068, Compound 27) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM336991![]() (US9745291, Compound 37 | US9765068, Compound 37) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337001![]() (US9745291, Compound 47 | US9765068, Compound 47) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337003![]() (US9745291, Compound 49 | US9765068, Compound 49) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337018![]() (US9745291, Compound 64 | US9765068, Compound 64) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337021![]() (US9745291, Compound 67 | US9765068, Compound 67) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337057![]() (US9745291, Compound 103 | US9765068, Compound 103) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337123![]() (US9745291, Compound 169 | US9765068, Compound 169) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337155![]() (US9745291, Compound 201) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337156![]() (US9745291, Compound 202) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337175![]() (US9745291, Compound 221) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337192![]() (US9745291, Compound 238) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337200![]() (US9745291, Compound 246) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337231![]() (US9745291, Compound 278A) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM336973![]() (US9745291, Compound 19 | US9765068, Compound 19) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM336974![]() (US9745291, Compound 20 | US9765068, Compound 20) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337034![]() (US9745291, Compound 80 | US9765068, Compound 80) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337047![]() (US9745291, Compound 93 | US9765068, Compound 93) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337055![]() (US9745291, Compound 101 | US9765068, Compound 101) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337059![]() (US9745291, Compound 105 | US9765068, Compound 105) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337062![]() (US9745291, Compound 108 | US9765068, Compound 108) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337084![]() (US9745291, Compound 130 | US9765068, Compound 130) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337169![]() (US9745291, Compound 215) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337180![]() (US9745291, Compound 226) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337206![]() (US9745291, Compound 253) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PRMT5/MEP50 Enzyme (Homo sapiens (Human)) | BDBM337019![]() (US9745291, Compound 65 | US9765068, Compound 65) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme Inc US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween20, prepared on the day of use.... | US Patent US9745291 (2017) BindingDB Entry DOI: 10.7270/Q2J1058K | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 277 total ) | Next | Last >> |